Results 201 to 210 of about 13,418,784 (259)

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

Internalized Stigma, Insight, Social Anxiety and Quality of Life in First-Episode Psychosis: A Cross-Sectional Study. [PDF]

Healthcare (Basel)
Toki EI, Karampas A, Markozannes G, Ntourou I, Asimakopoulos AG, Ntouros E, Plakoutsis M, Georgiou G, Kotsis K, Petrakou S, Siafaka V, Petrikis P.   +11 more
europepmc   +1 more source

Distinct Neuropsychiatric Profiles Associated With 17p11.2 Deletions and RAI1 Variants in Smith–Magenis Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2320-2330, October 2026.
ABSTRACT Smith–Magenis syndrome (SMS) results from either a recurrent 17p11.2 deletion or pathogenic variants in the retinoic acid induced 1 gene (RAI1). While neurodevelopmental impairment and behavioral dysregulation are well recognized, systematic genotype‐stratified analyses across psychiatric domains remain limited.
Albin Blanc, Christophe Nemos, Céline Bonnet, Mathilde Renaud, Sandra Chapuis, Pauline Boiroux, Marie‐Noëlle Babinet, Caroline Demily   +7 more
wiley   +1 more source

Diagnosis of an Arachnoid Cyst in a Patient Presenting With Uncommon Depressive Symptoms: Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Arachnoid cysts are most commonly asymptomatic and usually do not need any active treatment. Currently, psychiatric symptoms are seldom taken into consideration during treatment evaluations in this patient population. We present this case of a young man who was treated in our hospital for signs of depression.
Ruth Arias‐Hidalgo, Felipe Ortuño, Sergio Manuel Solís‐Barquero, Maria Fernández‐Seara, Reyes García de Eulate, Aziz Yarkin   +5 more
wiley   +1 more source

Neurophysiological subtyping of schizophrenia reveals a reproducible phenotype with temporoparietal circuit disruptions

General Psychiatry, Volume 39, Issue 5, October 2026.
ABSTRACT Background Heterogeneity in schizophrenia (SCZ) remains a major obstacle to the development of effective treatment. Aims This study aimed to identify reproducible neurobiological subtypes of SCZ using source‐localised, high‐density resting‐state electroencephalography (EEG) functional connectivity patterns.
Yue Ding, Xingxing Li, Junlin Liu, Guolin Jin, Weiwen Tian, Tifei Yuan, Wei Wu, Dongsheng Zhou   +7 more
wiley   +1 more source

Voices from Within: Saudi Arabian Women's Lived Experiences of First-Episode Psychosis, Hospitalisation, and Recovery Pathways. [PDF]

Healthcare (Basel)
Almutairi AS, Alghamdi A, Alyahya NM, Almutairy BM, Alodhailah AM, Almutairi AA, Alshaibany FF, Alshehri WM, Eid T.   +8 more
europepmc   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 277-285, October 2026.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta Psychiatrica Scandinavica, Volume 154, Issue 4, Page 286-295, October 2026.
ABSTRACT Objective For decades, a persistent claim has been that autobiographical memory loss after electroconvulsive therapy (ECT) for depression might actually contribute to ECT efficacy by reducing or even eliminating autobiographical memories. To test this claim, the primary aim of this study is to examine the association between autobiographical ...
Mike van Kessel, Joris van der Vlugt‐Molenaar, Isidoor O. Bergfeld, Eric van Exel, Jaap Murre, Jasmien Obbels, Pascal Sienaert, Kristof Vansteelandt, Esmée Verwijk   +8 more
wiley   +1 more source